Extracorporeal membrane oxygenation in nontraumatic critical care: new horizons in resuscitation

Extracorporeal membrane oxygenation (ECMO) transfers blood from a large vein into a machine, oxygenates it, and then reinfuses the oxygenated blood back to the patient through a large vascular catheter. Resuscitation procedures using ECMO are known as extracorporeal cardiopulmonary resuscitation or extracorporeal life support. On one hand, the procedure is suitable for selected patients with severe respiratory diseases, cardiogenic or septic shock, intoxications, thyrotoxicosis, trauma, or cardiac arrest. On the other hand, geriatric persons with multiple diseases, end-stage malignancies, those with cardiopulmonary diseases, or dementia are not candidates for extracorporeal cardiopulmonary resuscitation (ECPR). The potential indications for ECMO are still expanding, but well-designed, multicentric studies are needed to assess benefit and harms.

Extracorporeal membrane oxygenation; Extracorporeal cardiopulmonary resuscitation; Extracorporeal life support; Resuscitation; Survival; Cardiac arrest

[1] Richardson ASC, Tonna JE, Nanjayya V, Nixon P, Abrams DC, Raman L, et al. Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the Extracorporeal Life Support Organization. ASAIO Journal. 2021; 67: 221–228.

[2] White A, Fan E. What is ECMO? American Journal of Respiratory and Critical Care Medicine. 2016; 193: P9–P10.

[3] Greif R, Bray JE, Djärv T, Drennan IR, Liley HG, Ng KC, et al. International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations: summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces. Circulation. 2024; 150: e580–e687.

[4] Belohlavek J, Smalcova J, Rob D, Franek O, Smid O, Pokorna M, et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2022; 327: 737–747.

[5] Suverein MM, Delnoij TSR, Lorusso R, Brandon Bravo Bruinsma GJ, Otterspoor L, Elzo Kraemer CV, et al. Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. The New England Journal of Medicine. 2023; 388: 299–309.

[6] Swol J, Belohlávek J, Haft J, Ichiba S, Lorusso R, Peek G. Conditions and procedures for in-hospital extracorporeal life support (ECLS) in cardiopulmonary resuscitation (CPR) of adult patients. Perfusion. 2016; 31: 182–188.

[7] Supady A, Bělohlávek J, Combes A, Hutin A, Lorusso R, MacLaren G, et al. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest. The Lancet Respiratory Medicine. 2025; 13: 843–856.

[8] Swedzky F, Barbagelata A, Perrone S, Kaplinsky E, Ducharme A. Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO). Drugs in Context. 2023; 12: 2022-7-7.

[9] Yang Y, Wang X, Huang J, Lu X, Xiao Z. Extracorporeal membrane oxygenation for refractory septic shock in children. Signa Vitae. 2024; 20: 1–7.

[10] Chou TH, Fang CC, Yen ZS, Lee CC, Chen YS, Ko WJ, et al. An observational study of extracorporeal CPR for in-hospital cardiac arrest secondary to myocardial infarction. Emergency Medicine Journal. 2014; 31: 441–447.

[11] Haneya A, Philipp A, Diez C, Schopka S, Bein T, Zimmermann M, et al. A 5-year experience with cardiopulmonary resuscitation using extracorporeal life support in non-postcardiotomy patients with cardiac arrest. Resuscitation. 2012; 83: 1331–1337.

[12] Badulak J, Abrams D, Luks AM, Zakhary B, Conrad SA, Bartlett R, et al.; Extracorporeal Life Support Organization (ELSO). Position paper on the physiology and nomenclature of dual circulation during venoarterial ECMO in adults. Intensive Care Medicine. 2024; 50: 1994–2004.

[13] Wang L, Li C, Hao X, Rycus P, Tonna JE, Alexander P, et al. Percutaneous cannulation is associated with lower rate of severe neurological complication in femoro-femoral ECPR: results from the Extracorporeal Life Support Organization registry. Annals of Intensive Care. 2023; 13: 77.

[14] Danial P, Hajage D, Nguyen LS, Mastroianni C, Demondion P, Schmidt M, et al. Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study. Intensive Care Medicine. 2018; 44: 2153–2161.

[15] Simons J, Di Mauro M, Mariani S, Ravaux J, van der Horst ICC, Driessen RGH, et al. Bilateral femoral cannulation is associated with reduced severe limb ischemia-related complications compared with unilateral femoral cannulation in adult peripheral venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support registry. Critical Care Medicine. 2024; 52: 80–91.

[16] Pavlushkov E, Berman M, Valchanov K. Cannulation techniques for extracorporeal life support. Annals of Translational Medicine. 2017; 5: 70.

[17] Wang L, Wang Y, Fu H, Meng X, Li C, Jiang C, et al. Feasibility of standby ECMO with preset femoral vascular sheaths for high-risk transcatheter aortic valve replacement. Perfusion. 2025; 40: 893–897.

[18] Reddy S, Garcia S, Hostetter LJ, Finch AS, Bellolio F, Guru P, et al. Extracorporeal-CPR versus conventional-CPR for adult patients in out of hospital cardiac arrest—systematic review and meta-analysis. Journal of Intensive Care Medicine. 2025; 40: 207–217.

[19] Burrell A, Kim J, Alliegro P, Romero L, Serpa Neto A, Mariajoseph F, et al. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database of Systematic Reviews. 2023; 9: CD010381.

[20] Zhang Y, Zhang L, Huang X, Ma N, Wang P, Li L, et al. ECMO in adult patients with severe trauma: a systematic review and metaanalysis. European Journal of Medical Research. 2023; 28: 412.

[21] Maekawa K, Tanno K, Hase M, Mori K, Asai Y. Extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest of cardiac origin: a propensity-matched study and predictor analysis. Critical Care Medicine. 2013; 41: 1186–1196.

[22] Cho SM, Hwang J, Chiarini G, Amer M, Antonini MV, Barrett N, et al. Neurological monitoring and management for adult extracorporeal membrane oxygenation patients: Extracorporeal Life Support Organization Consensus Guidelines. Critical Care. 2024; 28: 296.

[23] Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015; 86: 88–94.

[24] Dennis M, Buscher H, Gattas D, Burns B, Habig K, Bannon P, et al.; Sydney ECMO Research Interest Group. Prospective observational study of mechanical cardiopulmonary resuscitation, extracorporeal membrane oxygenation and early reperfusion for refractory cardiac arrest in Sydney: the 2CHEER study. Critical Care and Resuscitation. 2020; 22: 26–34.

[25] Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, et al.; ELSO Guideline Working Group. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. ASAIO Journal. 2020; 66: 707–721.

[26] Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al.; ECMO-CS Investigators. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023; 147: 454–464.

[27] Gallegos-Koyner FJ, Barrera NI, Teferi AM, Jou K, Cerrud-Rodriguez RC, Chong DH. Extracorporeal membrane oxygenation outcomes: COVID-19 pneumonia vs non-COVID-19 pneumonia. American Journal of Critical Care. 2025; 34: 104–110.

[28] Flatley M, Sams VG, Biscotti M Ⅲ, Deshpande SJ, Usman AA, Cannon JW. ECMO in trauma care: what you need to know. The Journal of Trauma and Acute Care Surgery. 2024; 96: 186–194.

[29] Vajter J, Volod O. Anticoagulation management during ECMO: narrative review. JHLT Open. 2025; 8: 100216.

[30] Wood KL, Ayers B, Gosev I, Kumar N, Melvin AL, Barrus B, et al. Venoarterial-extracorporeal membrane oxygenation without routine systemic anticoagulation decreases adverse events. The Annals of Thoracic Surgery. 2020; 109: 1458–1466.

[31] Zhang C, Wang Q, Lu A. ECMO for bridging lung transplantation. European Journal of Medical Research. 2024; 29: 628.

[32] Rajsic S, Treml B. Anticoagulation monitoring during ECMO support: monitor or flip a coin? Clinical Cardiology. 2024; 47: e70061.

[33] Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Seminars in Thrombosis and Hemostasis. 2018; 44: 20–29.

[34] Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, et al. Extracorporeal membrane oxygenation hemostatic complications. Transfusion Medicine Reviews. 2015; 29: 90–101.

[35] Kim HS, Ha SO, Han SJ, Kim HS, Lee SH, Jung KS, et al. Extracorporeal membrane oxygenation support in trauma versus nontrauma patients with noninfectious acute respiratory failure. Artificial Organs. 2017; 41: 431–439.

[36] Orso D, Fodale CM, Fossati S, Venturini S, Fonda F, Cugini F, et al. Do patients receiving extracorporeal membrane-oxygenation need antibiotic prophylaxis? A systematic review and meta-analysis on 7996 patients. BMC Anesthesiology. 2024; 24: 410.

[37] Martínez-Sellés M, Hernández-Pérez FJ, Uribarri A, Martín Villén L, Zapata L, Alonso JJ, et al. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care. Revista Española de Cardiología. 2023; 76: 261–269.

[38] Birkner DR, Halvachizadeh S, Pape HC, Pfeifer R. Mortality of adult respiratory distress syndrome in trauma patients: a systematic review over a period of four decades. World Journal of Surgery. 2020; 44: 2243–2254.

[39] Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Annals of Surgery. 2004; 240: 595–605; discussion 605–607.

[40] Schmidt M, Hodgson C, Combes A. Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review. Critical Care. 2015; 19: 99.

[41] Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al.; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. The Lancet. 2009; 374: 1351–1363.

[42] Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. The New England Journal of Medicine. 2013; 368: 2159–2168.

[43] Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal life support organization. extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. The Lancet. 2020; 396: 1071–1078.

[44] Bertini P, Guarracino F, Falcone M, Nardelli P, Landoni G, Nocci M, et al. ECMO in COVID-19 patients: a systematic review and meta-analysis. Journal of Cardiothoracic and Vascular Anesthesia. 2022; 36: 2700–2706.

[45] Chandel A, Puri N, Damuth E, Potestio C, Peterson LN, Ledane J, et al. Extracorporeal membrane oxygenation for COVID-19: comparison of outcomes to non-COVID-19-related viral acute respiratory distress syndrome from the Extracorporeal Life Support Organization registry. Critical Care Explorations. 2023; 5: e0861.

[46] Hermann M, Filipsky R, Bukowski N, Gerger G, Hermann A, Krenn K, et al. Long-term health-related quality of life following survival of acute respiratory distress syndrome and extracorporeal membrane oxygenation due to COVID-19. Journal of Clinical Medicine. 2025; 14: 3358.

[47] Staudacher DL, Felder M, Jäckel M, Rottmann FA, Supady A, Bemtgen X, et al. Quality of life and mental health in COVID-ARDS survivors after V-V ECMO support: results from the Freiburg Ecmo Outcome Study (FEOS). Journal of Clinical Medicine. 2025; 14: 2206.

[48] Donnan MT, Zhao P, Cheng AC, Ibrahim A, Palermo A, Reddi B, et al. In-hospital mortality in patients admitted to Australian intensive care units with COVID-19 between 2020 and 2024. Critical Care and Resuscitation. 2025; 27: 100094.

[49] Sklienka P, Burša F, Frelich M, Máca J, Romanová T, Vodička V, et al. Lessons learned from awake ECMO approach in Covid-19-related acute respiratory distress syndrome—a scoping review. Therapeutics and Clinical Risk Management. 2025; 21: 655–668.

[50] Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S; Toxicology Investigators Consortium. Extracorporeal membrane oxygenation (ECMO) for severe toxicological exposures: review of the toxicology investigators consortium (ToxIC). Journal of Medical Toxicology. 2016; 12: 95–99.

[51] Simpson MD, Tang KB, Donnino MW, Chai PR, Culbreth R, Campleman S, et al.; Toxicology Investigators Consortium. Clinical factors associated with ventricular dysrhythmia in emergency department patients with severe QTc prolongation after drug overdose. Academic Emergency Medicine. 2025. PMID: 40492421.

[52] Daubin C, Lehoux P, Ivascau C, Tasle M, Bousta M, Lepage O, et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Critical Care. 2009; 13: R138.

[53] Maruniak S, Tkachenko D, Swol J, Sternberg T, Hoffmann J. The dosage makes the poison—ECMO support considerations in poisoning. Perfusion. 2025; 40: 54S–61S.

[54] Lavonas EJ, Akpunonu PD, Arens AM, Babu KM, Cao D, Hoffman RS, et al. 2023 American Heart Association focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoning: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2023; 148: e149–e184.

[55] Kim HK, Piner AO, Day LN, Jones KM, Alunnifegatelli D, Di Nardo M. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) for acute poisonings in United States: a retrospective analysis of the Extracorporeal Life Support Organization registry. Clinical Toxicology. 2025; 63: 204–211.

[56] Cole JB, Olives TD, Ulici A, Litell JM, Bangh SA, Arens AM, et al. Extracorporeal membrane oxygenation for poisonings reported to U.S. poison centers from 2000 to 2018: an analysis of the National Poison Data System. Critical Care Medicine. 2020; 48: 1111–1119.

[57] Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012; 83: 1413–1417.

[58] Kantimathinathan S, Thangaraj PR, Sunder T, Kuppuswamy MK, Chinnasamy S, Sriraman KB, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation following paraquat poisoning. Indian Journal of Thoracic and Cardiovascular Surgery. 2025; 41: 1027–1032.

[59] Meng F, Zhang Y, Cai H, Meng F, Liu B, Li Y. Lung transplant success in severe diquat poisoning: a case report. American Journal of Case Reports. 2025; 26: e947421.

[60] Pervaiz Butt S, Kakar V, Abdulaziz S, Razzaq N, Saleem Y, Kumar A, et al. Enhancing lung transplantation with ECMO: a comprehensive review of mechanisms, outcomes, and future considerations. The Journal of ExtraCorporeal Technology. 2024; 56: 191–202.

[61] Wang W, Ji J, Han L, Pang J, Mo L, Liu F, et al. Global hotspot and trend of extracorporeal membrane oxygenation for pulmonary embolism. Frontiers in Medicine. 2025; 12: 1531716.

[62] Yang SL, Gao Y, Han ZY, Du X, Liu W, Jin SG, et al. Successful treatment of near-fatal pulmonary embolism and cardiac arrest in an adult patient with fulminant psittacosis-induced severe acute respiratory distress syndrome after veno-venous extracorporeal membrane oxygenation rescue: a case report and follow-up. Heliyon. 2023; 9: e20562.

[63] Zampieri FG, Mendes PV, Ranzani OT, Taniguchi LU, Pontes Azevedo LC, Vieira Costa EL, et al. Extracorporeal membrane oxygenation for severe respiratory failure in adult patients: a systematic review and meta-analysis of current evidence. Journal of Critical Care. 2013; 28: 998–1005.

[64] Hart JP, Davies MG. Vascular complications in extracorporeal membrane oxygenation—a narrative review. Journal of Clinical Medicine. 2024; 13: 5170.

[65] Harnisch LO, Moerer O. Contraindications to the initiation of Veno-Venous ECMO for severe acute respiratory failure in adults: a systematic review and practical approach based on the current literature. Membranes. 2021; 11: 584.